-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PyqQcgIr72y4SRQlQXQmW0UEj4ntsRxkGbzwkSWaDK7MobrObTPyVyjprx7jB7pZ FyfzV0yTiMP5M/NP6Nx0EQ== 0001437749-10-003190.txt : 20101001 0001437749-10-003190.hdr.sgml : 20101001 20101001145950 ACCESSION NUMBER: 0001437749-10-003190 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100928 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Other Events FILED AS OF DATE: 20101001 DATE AS OF CHANGE: 20101001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tamir Biotechnology, Inc. CENTRAL INDEX KEY: 0000708717 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222369085 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11088 FILM NUMBER: 101102117 BUSINESS ADDRESS: STREET 1: 300 ATRIUM DRIVE CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: 732-652-4525 MAIL ADDRESS: STREET 1: 300 ATRIUM DRIVE CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: ALFACELL CORP DATE OF NAME CHANGE: 19920703 8-K 1 tamir_8k-100110.htm CURRENT REPORT tamir_8k-100110.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  September 28, 2010

Tamir Biotechnology, Inc.
(Exact name of registrant as specified in its charter)

0-11088
(Commission File Number)
 
Delaware
22-2369085
(State or other jurisdiction of
(I.R.S. Employer Identification No.)
incorporation)
  
 
11 Deer Park Drive, Suite 204, Princeton Corporate Plaza, Monmouth Junction, NJ 08852
(Address of principal executive offices, with zip code)

(732) 823-1003
(Registrant's telephone number, including area code)

300 Atrium Drive, Somerset, NJ 08873
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 1.01 Entry Into a Material Definitive Agreement.
 
On September 28, 2010, Tamir Biotechnology, Inc. (the "Company") entered into an Office Lease Agreement (the "Lease Agreement"), effective as of October 1, 2010, with Princeton Corporate Plaza, LLC, (the "Landlord"), whereby the Company has leased 2,046 square feet of office and laboratory space in the building located at 11 Deer Park Drive, Suite 204, in the township of South Brunswick in the County of Middlesex, State of New Jersey (the "Building").  The new office will replace 300 Atrium Drive, Somerset, New Jersey 08873 as the Company's principal executive offices. The lease term will begin on October 1, 2010 (the "Commencement Date”), ending on September 30, 2011 (the “Expiration Date”).  The Company will be required to p ay rent including expenses of $3,794 per month.
 
The  foregoing  description  is  qualified  in its entirety by reference to the Lease Agreement, which will be filed as an exhibit to the Company's next annual report on Form 10-K.

Item 8.01 Other Events.
 
On October 1, 2010, the Company moved its principal executive offices and corporate headquarters from 300 Atrium Drive, Somerset, New Jersey 08873 to a facility with a postal address at 11 Deer Park Drive, Suite 204, Princeton Corporate Plaza, Monmouth Junction, New Jersey 08852.  As a result of the move, the Company can now be reached via telephone at (732) 823-1003, and via fax at (732) 230-3794. The terms of the lease for the new office space are governed by that certain Lease Agreement by and between the Company and the Landlord, as disclosed above.

 
 
 

SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
  TAMIR BIOTECHNOLOGY, INC.  
       
Date: October 01, 2010
By:
/s/ Charles Muniz  
    Charles Muniz  
   
President, Chief Executive Officer and
Chief Financial Officer
  
-----END PRIVACY-ENHANCED MESSAGE-----